Levofloxacin
28 NDCs across 9 manufacturers|28 Generic,0 Brand
Levofloxacin is used to treat bronchitis, chlamydia infections, escherichia coli infections, bacterial eye infections, haemophilus infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 20, 1996, and the first generic was approved Dec 20, 2010. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $15 million on Levofloxacin across 2.5 million claims for 1.9 million beneficiaries.
Levofloxacin is available as 28 NDCs from 9 manufacturers (28 generic, 0 brand), with NADAC prices from $0.11 to $0.26 per EA — the most expensive product costs about 2.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
28
28G / 0B
Manufacturers
9
competing in market
Price Spread
$0.11 – $0.26
per EA, 22 of 28 NDCs
7d Activity
avg -3.7% WoW · of 28 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Viona Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing LEVOFLOXACIN(2 pricing outliers)
Frequently Asked Questions
What is Levofloxacin used to treat?
Levofloxacin is used to treat bronchitis, chlamydia infections, escherichia coli infections, bacterial eye infections, haemophilus infections and klebsiella infections, per the National Library of Medicine's MED-RT classification.
When did Levofloxacin become available as a generic?
FDA approved the first generic Levofloxacin (ANDA) on Dec 20, 2010. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Levofloxacin?
In 2024, Medicare Part D spent $15 million on Levofloxacin across 2.5 million claims for 1.9 million beneficiaries.
How many Levofloxacin products are on the market?
The Levofloxacin drug market contains 28 NDCs from 9 manufacturers — 28 generic and 0 brand products.
What is the price range for Levofloxacin?
NADAC reference prices for Levofloxacin range from $0.1086 to $0.2586 per EA — the most expensive product costs about 2.4× the cheapest. 6 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Levofloxacin?
9 manufacturers list Levofloxacin in NADAC. Ranked by number of NDCs, the largest are Viona Pharmaceuticals Inc. (4), Lannett Company Inc. (3), ANI Pharmaceuticals, Inc. (3), Major Pharmaceuticals (3), Camber Pharmaceuticals Inc. (3).
How has the price of Levofloxacin changed recently?
Over the past 7 days, 0 Levofloxacin NDCs rose and 26 fell, with a market-wide average change of -3.7%.